Dr. Audrey E. Spelde, MD

Dr. Spelde practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Spelde's NPI, 1740677566, was assigned on April 20, 2015. Dr. Spelde graduated from George Washington University School of Medicine in 2015. Dr. Spelde holds Pennsylvania license MD467058.

Dr. Spelde's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.

Dr. Spelde's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Spelde is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Spelde to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spelde practices, 2 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Spelde's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Spelde is licensed in Pennsylvania.

CMS data shows 217 Medicare services from Dr. Spelde across 4 procedure codes in 2024, for 144 Medicare patients. Medicare paid $29,725 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw Dr. Spelde in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spelde's median patient age at 61, with 30% women.

In 2018, Dr. Spelde wrote 14 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $231 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Spelde for performance year 2024, reported as part of a group. Dr. Spelde accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Spelde, published from 2016 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Extracorporeal Membrane Oxygenation, Heart-Assist Devices and COVID-19. Dr. Spelde has published most often in J Cardiothorac Vasc Anesth. Dr. Spelde's most frequent co-authors are Asad Ali Usman, MD, MPH, Marisa Cevasco, MD, MPH and William J. Vernick, MD.

CMS Open Payments shows 5 general payments to Dr. Spelde from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. LivaNova USA, Inc. paid the most, $169.

Dr. Spelde graduated from George Washington University School of Medicine in 2015.